177 related articles for article (PubMed ID: 38769124)
1. Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo.
Sun X; Shi C; Dai J; Zhang MQ; Pei DS; Yang L
Cell Death Dis; 2024 May; 15(5):346. PubMed ID: 38769124
[TBL] [Abstract][Full Text] [Related]
2. Expression and functional implications of YME1L in nasopharyngeal carcinoma.
Cheng F; Huang H; Yin S; Liu JS; Sun P
Cell Death Dis; 2024 Jun; 15(6):423. PubMed ID: 38890304
[TBL] [Abstract][Full Text] [Related]
3. The mitochondrial protein YME1 Like 1 is important for non-small cell lung cancer cell growth.
Xia Y; He C; Hu Z; Wu Z; Hui Y; Liu YY; Mu C; Zha J
Int J Biol Sci; 2023; 19(6):1778-1790. PubMed ID: 37063426
[TBL] [Abstract][Full Text] [Related]
4. Targeting POLRMT by a first-in-class inhibitor IMT1 inhibits osteosarcoma cell growth in vitro and in vivo.
Kong Y; Li X; Zhang H; Fu B; Jiang HY; Yang HL; Dai J
Cell Death Dis; 2024 Jan; 15(1):57. PubMed ID: 38228583
[TBL] [Abstract][Full Text] [Related]
5. Overexpressed Gαi1 exerts pro-tumorigenic activity in nasopharyngeal carcinoma.
Yin DP; Zhang H; Teng H; Zhang D; Chen P; Xie L; Liu JS
Cell Death Dis; 2023 Dec; 14(12):792. PubMed ID: 38049415
[TBL] [Abstract][Full Text] [Related]
6. HOXC13-driven TIMM13 overexpression promotes osteosarcoma cell growth.
Han Q; Yan P; Song R; Liu F; Tian Q
Cell Death Dis; 2023 Jul; 14(7):398. PubMed ID: 37407582
[TBL] [Abstract][Full Text] [Related]
7. Identification of Gαi3 as a promising target for osteosarcoma treatment.
Bian ZJ; Shan HJ; Zhu YR; Shi C; Chen MB; Huang YM; Wang XD; Zhou XZ; Cao C
Int J Biol Sci; 2022; 18(4):1508-1520. PubMed ID: 35280670
[TBL] [Abstract][Full Text] [Related]
8. Deregulation of CLTC interacts with TFG, facilitating osteosarcoma via the TGF-beta and AKT/mTOR signaling pathways.
Shijie L; Zhen P; Kang Q; Hua G; Qingcheng Y; Dongdong C
Clin Transl Med; 2021 Jun; 11(6):e377. PubMed ID: 34185412
[TBL] [Abstract][Full Text] [Related]
9. ADCK1 is a potential therapeutic target of osteosarcoma.
Zhuo BB; Zhu LQ; Yao C; Wang XH; Li SX; Wang R; Li Y; Ling ZY
Cell Death Dis; 2022 Nov; 13(11):954. PubMed ID: 36371387
[TBL] [Abstract][Full Text] [Related]
10. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
Zhang Y; Cheng H; Li W; Wu H; Yang Y
Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of REG3A promotes tumorigenic behavior in triple negative breast cancer cells.
Jin X; Yang S; Lu X; Chen X; Dai W
Breast Cancer Res; 2024 Jun; 26(1):92. PubMed ID: 38840145
[TBL] [Abstract][Full Text] [Related]
12. Calycosin, a Phytoestrogen Isoflavone, Induces Apoptosis of Estrogen Receptor-Positive MG-63 Osteosarcoma Cells via the Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Sun H; Yin M; Qian W; Yin H
Med Sci Monit; 2018 Sep; 24():6178-6186. PubMed ID: 30182951
[TBL] [Abstract][Full Text] [Related]
13. PSMC2 is up-regulated in osteosarcoma and regulates osteosarcoma cell proliferation, apoptosis and migration.
Song M; Wang Y; Zhang Z; Wang S
Oncotarget; 2017 Jan; 8(1):933-953. PubMed ID: 27888613
[TBL] [Abstract][Full Text] [Related]
14. Heat shock protein 90B1 plays an oncogenic role and is a target of microRNA-223 in human osteosarcoma.
Li G; Cai M; Fu D; Chen K; Sun M; Cai Z; Cheng B
Cell Physiol Biochem; 2012; 30(6):1481-90. PubMed ID: 23208072
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of KRT17 decreases osteosarcoma cell proliferation and the Warburg effect via the AKT/mTOR/HIF1α pathway.
Yan X; Yang C; Hu W; Chen T; Wang Q; Pan F; Qiu B; Tang B
Oncol Rep; 2020 Jul; 44(1):103-114. PubMed ID: 32627037
[TBL] [Abstract][Full Text] [Related]
16. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway.
Zheng J; Liu C; Shi J; Wen K; Wang X
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913077
[TBL] [Abstract][Full Text] [Related]
17. TGF-β is associated with poor prognosis and promotes osteosarcoma progression
Ma K; Zhang C; Li W
Cell Cycle; 2020 Sep; 19(18):2327-2339. PubMed ID: 32804027
[TBL] [Abstract][Full Text] [Related]
18. A first-in-class TIMM44 blocker inhibits bladder cancer cell growth.
Zhang L; Shi X; Zhang L; Mi Y; Zuo L; Gao S
Cell Death Dis; 2024 Mar; 15(3):204. PubMed ID: 38467612
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of RSK2 influences the biological activities of human osteosarcoma cells through inactivating AKT/mTOR signaling pathways.
Qiu Q; Jiang J; Lin L; Cheng S; Xin D; Jiang W; Shen J; Hu Z
Int J Oncol; 2016 Jun; 48(6):2508-20. PubMed ID: 27082640
[TBL] [Abstract][Full Text] [Related]
20. Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer.
Peng SQ; Zhu XR; Zhao MZ; Zhang YF; Wang AR; Chen MB; Ye ZY
Cell Death Dis; 2023 Feb; 14(2):157. PubMed ID: 36828810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
